Annual Total Long Term Liabilities
$204.00 K
-$76.00 K-27.14%
December 31, 2023
Summary
- As of February 10, 2025, ABIO annual total long term liabilities is $204.00 thousand, with the most recent change of -$76.00 thousand (-27.14%) on December 31, 2023.
- During the last 3 years, ABIO annual total long term liabilities has fallen by -$205.00 thousand (-50.12%).
Performance
ABIO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
June 30, 2024
Summary
- As of February 10, 2025, ABIO quarterly total long term liabilities is $0.00, unchanged on June 30, 2024.
- Over the past year, ABIO quarterly long term liabilities has dropped by -$204.00 thousand (-100.00%).
Performance
ABIO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ABIO Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.1% | -100.0% |
| 3 y3 years | -50.1% | -100.0% |
| 5 y5 years | +100.0% | -100.0% |
ABIO Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.7% | at low | -100.0% | at low |
| 5 y | 5-year | -50.1% | -100.0% | -100.0% | at low |
| alltime | all time | -99.7% | -100.0% | -100.0% | at low |
ARCA Biopharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) |
| Dec 2023 | $204.00 K(-27.1%) | $204.00 K(-8.9%) |
| Sep 2023 | - | $224.00 K(-7.8%) |
| Jun 2023 | - | $243.00 K(-7.3%) |
| Mar 2023 | - | $262.00 K(-6.4%) |
| Dec 2022 | $280.00 K(-26.9%) | $280.00 K(-7.0%) |
| Sep 2022 | - | $301.00 K(-8.5%) |
| Jun 2022 | - | $329.00 K(-7.8%) |
| Mar 2022 | - | $357.00 K(-6.8%) |
| Dec 2021 | $383.00 K(-6.4%) | $383.00 K(-6.6%) |
| Sep 2021 | - | $410.00 K(-5.7%) |
| Jun 2021 | - | $435.00 K(+10.4%) |
| Mar 2021 | - | $394.00 K(-3.7%) |
| Dec 2020 | $409.00 K(>+9900.0%) | $409.00 K(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $4000.00(-55.6%) |
| Jun 2018 | - | $9000.00(-40.0%) |
| Mar 2018 | - | $15.00 K(-25.0%) |
| Dec 2017 | $20.00 K(-48.7%) | $20.00 K(-20.0%) |
| Sep 2017 | - | $25.00 K(-16.7%) |
| Jun 2017 | - | $30.00 K(-14.3%) |
| Mar 2017 | - | $35.00 K(-10.3%) |
| Dec 2016 | $39.00 K(>+9900.0%) | $39.00 K(-9.3%) |
| Sep 2016 | - | $43.00 K(-8.5%) |
| Jun 2016 | - | $47.00 K(>+9900.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(-100.0%) |
| Jun 2015 | - | $1000.00(0.0%) |
| Mar 2015 | - | $1000.00(-66.7%) |
| Dec 2014 | $3000.00(+200.0%) | $3000.00(0.0%) |
| Sep 2014 | - | $3000.00(+50.0%) |
| Jun 2014 | - | $2000.00(+100.0%) |
| Mar 2014 | - | $1000.00(0.0%) |
| Dec 2013 | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(-100.0%) |
| Mar 2012 | - | $8000.00(-50.0%) |
| Dec 2011 | $16.00 K(-91.8%) | $16.00 K(-36.0%) |
| Sep 2011 | - | $25.00 K(-21.9%) |
| Jun 2011 | - | $32.00 K(-80.4%) |
| Mar 2011 | - | $163.00 K(-16.4%) |
| Dec 2010 | $195.00 K | $195.00 K(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $226.00 K(-12.1%) |
| Jun 2010 | - | $257.00 K(-10.1%) |
| Mar 2010 | - | $286.00 K(-9.5%) |
| Dec 2009 | $316.00 K(-99.1%) | $316.00 K(-88.2%) |
| Sep 2009 | - | $2.69 M(-19.0%) |
| Jun 2009 | - | $3.32 M(-71.6%) |
| Mar 2009 | - | $11.66 M(-65.1%) |
| Dec 2008 | $33.43 M(-4.0%) | $33.43 M(+104.6%) |
| Sep 2008 | - | $16.34 M(-9.9%) |
| Jun 2008 | - | $18.14 M(-8.7%) |
| Mar 2008 | - | $19.87 M(-43.0%) |
| Dec 2007 | $34.84 M(-50.7%) | $34.84 M(-4.7%) |
| Sep 2007 | - | $36.57 M(-4.7%) |
| Jun 2007 | - | $38.39 M(-43.5%) |
| Mar 2007 | - | $67.98 M(-3.9%) |
| Dec 2006 | $70.72 M(+368.4%) | $70.72 M(+26.8%) |
| Sep 2006 | - | $55.78 M(+9.8%) |
| Jun 2006 | - | $50.81 M(-3.7%) |
| Mar 2006 | - | $52.76 M(+249.4%) |
| Dec 2005 | $15.10 M(+36.5%) | $15.10 M(+63.9%) |
| Sep 2005 | - | $9.21 M(-10.4%) |
| Jun 2005 | - | $10.28 M(-6.7%) |
| Mar 2005 | - | $11.02 M(-0.4%) |
| Dec 2004 | $11.06 M(-47.4%) | $11.06 M(+11.9%) |
| Sep 2004 | - | $9.89 M(-26.0%) |
| Jun 2004 | - | $13.37 M(-7.0%) |
| Mar 2004 | - | $14.38 M(-31.6%) |
| Dec 2003 | $21.02 M(+318.3%) | $21.02 M(+159.4%) |
| Sep 2003 | - | $8.10 M(-5.9%) |
| Jun 2003 | - | $8.61 M(+31.5%) |
| Mar 2003 | - | $6.55 M(+30.3%) |
| Dec 2002 | $5.03 M(-20.9%) | $5.03 M(-5.0%) |
| Sep 2002 | - | $5.29 M(-7.5%) |
| Jun 2002 | - | $5.72 M(-5.3%) |
| Mar 2002 | - | $6.04 M(-4.9%) |
| Dec 2001 | $6.35 M(+34.5%) | $6.35 M(+118.2%) |
| Sep 2001 | - | $2.91 M(-15.7%) |
| Jun 2001 | - | $3.45 M(-15.8%) |
| Mar 2001 | - | $4.10 M(-13.1%) |
| Dec 2000 | $4.72 M(-10.9%) | $4.72 M(-11.5%) |
| Sep 2000 | - | $5.33 M(-10.0%) |
| Jun 2000 | - | $5.93 M(+25.2%) |
| Mar 2000 | - | $4.74 M(-10.6%) |
| Dec 1999 | $5.30 M(+20.5%) | $5.30 M(+1.9%) |
| Sep 1999 | - | $5.20 M(+10.6%) |
| Jun 1999 | - | $4.70 M(+11.9%) |
| Mar 1999 | - | $4.20 M(-4.5%) |
| Dec 1998 | $4.40 M(+528.6%) | $4.40 M(+528.6%) |
| Sep 1998 | - | $700.00 K(+40.0%) |
| Jun 1998 | - | $500.00 K(-16.7%) |
| Mar 1998 | - | $600.00 K(-14.3%) |
| Dec 1997 | $700.00 K(-12.5%) | $700.00 K(-12.5%) |
| Sep 1997 | - | $800.00 K(0.0%) |
| Jun 1997 | - | $800.00 K(+33.3%) |
| Mar 1997 | - | $600.00 K |
| Dec 1996 | $800.00 K | - |
FAQ
- What is ARCA biopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for ARCA biopharma?
- What is ARCA biopharma annual total long term liabilities year-on-year change?
- What is ARCA biopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ARCA biopharma?
- What is ARCA biopharma quarterly long term liabilities year-on-year change?
What is ARCA biopharma annual total long term liabilities?
The current annual total long term liabilities of ABIO is $204.00 K
What is the all time high annual total long term liabilities for ARCA biopharma?
ARCA biopharma all-time high annual total long term liabilities is $70.72 M
What is ARCA biopharma annual total long term liabilities year-on-year change?
Over the past year, ABIO annual total long term liabilities has changed by -$76.00 K (-27.14%)
What is ARCA biopharma quarterly total long term liabilities?
The current quarterly long term liabilities of ABIO is $0.00
What is the all time high quarterly long term liabilities for ARCA biopharma?
ARCA biopharma all-time high quarterly total long term liabilities is $70.72 M
What is ARCA biopharma quarterly long term liabilities year-on-year change?
Over the past year, ABIO quarterly total long term liabilities has changed by -$204.00 K (-100.00%)